- Home
- CTNM vs DENN Comparison
CTNM vs DENN Comparison
Compare CTNM & DENN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTNM
- DENN
- Stock Information
- Founded
- CTNM 2009
- DENN 1953
- Country
- CTNM United States
- DENN United States
- Employees
- CTNM N/A
- DENN N/A
- Industry
- CTNM
- DENN Restaurants
- Sector
- CTNM
- DENN Consumer Discretionary
- Exchange
- CTNM Nasdaq
- DENN Nasdaq
- Market Cap
- CTNM 378.7M
- DENN 329.8M
- IPO Year
- CTNM 2024
- DENN 1989
- Fundamental
- Price
- CTNM $14.14
- DENN $6.20
- Analyst Decision
- CTNM Strong Buy
- DENN Strong Buy
- Analyst Count
- CTNM 4
- DENN 5
- Target Price
- CTNM $29.25
- DENN $7.70
- AVG Volume (30 Days)
- CTNM 82.5K
- DENN 717.8K
- Earning Date
- CTNM 11-06-2024
- DENN 02-11-2025
- Dividend Yield
- CTNM N/A
- DENN N/A
- EPS Growth
- CTNM N/A
- DENN N/A
- EPS
- CTNM N/A
- DENN 0.33
- Revenue
- CTNM N/A
- DENN $453,013,000.00
- Revenue This Year
- CTNM N/A
- DENN N/A
- Revenue Next Year
- CTNM N/A
- DENN $4.07
- P/E Ratio
- CTNM N/A
- DENN $19.12
- Revenue Growth
- CTNM N/A
- DENN N/A
- 52 Week Low
- CTNM $12.33
- DENN $5.37
- 52 Week High
- CTNM $22.00
- DENN $11.16
- Technical
- Relative Strength Index (RSI)
- CTNM N/A
- DENN 45.09
- Support Level
- CTNM N/A
- DENN $5.89
- Resistance Level
- CTNM N/A
- DENN $6.49
- Average True Range (ATR)
- CTNM 0.00
- DENN 0.24
- MACD
- CTNM 0.00
- DENN -0.00
- Stochastic Oscillator
- CTNM 0.00
- DENN 43.06
About CTNM Contineum Therapeutics Inc. Class A Common Stock
Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.
About DENN Denny's Corporation
Denny's Corp is one of America's franchised full-service restaurant chains based on the number of restaurants. The company owns and operates the Denny's brand and the Keke's Breakfast Cafe brand. It provides Pancakes, Appetizers & Soups, Sandwiches & Salads, Breakfast Melts, Omelets, and others. The company generates its revenue from two sources: the sale of food and beverages and the collection of royalties, advertising revenue, initial and other fees, including occupancy revenue, from restaurants operated by their franchisees.